Read as much as you want on, anywhere and anytime, for just 99¢.

Around the Region

Cubist drug gets expanded OK

Continue reading below

Cubist Pharmaceuticals Inc. said that the Food and Drug Administration has approved expanded use for Entereg, a drug used after gastrointestinal surgery.

Entereg is designed to accelerate healing following certain surgeries, Lexington-based Cubist said. Entereg was approved in the United States in 2008.

“Delayed GI (gastrointestinal) recovery is one of the most common causes of prolonged hospital stays in patients undergoing major abdominopelvic surgery,” Cubist chief scientific officer Steven Gilman said in a statement. “We are pleased that doctors will have the option to help speed GI recovery for appropriate patients who have undergone surgeries that included a bowel resection.”

Chris Reidy can be reached at
Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of